It also includes atopic dermatitis, or eczema ... 2025. Prurigo nodularis is a chronic inflammatory skin condition characterised by firm, itchy bumps or 'nodules' that appear on the skin after ...

Ruxolitinib cream 1.5% shows “breakthrough” results as a treatment for prurigo nodularis, according to a presenter at the ...

More than 40% of patients with longstanding prurigo nodularis (PN) had significant improvement within 3 months of starting ...

As Incyte strives to push its topical JAK inhibitor Opzelura into additional dermatology indications, the company’s latest ...

Dupixent scores a first in rare skin disease prurigo nodular... Sanofi and Regeneron's Dupixent has become the first biologic drug to show activity in prurigo nodularis (PN), raising the hope of a ...

Considering taking supplements to treat prurigo nodularis? Below is a list of common natural remedies used to treat or reduce the symptoms of prurigo nodularis. Follow the links to read common ...

Shawn Kwatra, MD, FAAD, physician scientist at the University of Maryland Medical System, presented data at the American Academy of Dermatology 2025 annual conference on the rapid efficacy of topical ...

Meanwhile, prurigo nodularis, which causes intense itch and thick skin nodules, is estimated to affect up to 111 people per 100,000 in the EU depending on the country. Despite available treatments, ...

IL-31 is a protein that drives itch and plays a role in inflammation and skin barrier dysfunction in both AD and prurigo nodularis ... with placebo plus TCS/TCI. Eczema Area and Severity Index ...

The drug, called nemolizumab and marketed as Nemluvio, is already on the market in the U.S. for prurigo nodularis, a chronic skin condition marked by intensely itchy nodules. The U.S. Food and ...

Nemluvio’s approved indications include atopic dermatitis in patients aged 12 years and older and prurigo nodularis in adults. The approvals are supported by two phase 3 clinical trial programs.

Atopic dermatitis, characterised by persistent itch and recurrent skin lesions, affects up to 1.6 million people in the UK, while prurigo nodularis, which causes intense itch and thick skin nodules, ...